Two insurers report losses
        Operational and regulatory burdens — not the typical severe-weather problems — made 2000 a bumpy year for two of the Tristate's largest insurance companies.

Suit filed over gas price deal
        A Symmes Township man has filed a class-action lawsuit on behalf of thousands of area customers of a former Cinergy Corp. unit, claiming it broke an agreement to provide natural gas to his home for less than half what he's now paying.

Are you confident in the economy?
Tell us what you think. Please take a moment to fill out our e-mail survey. Check the results from other readers.

Business Headlines for  Wednesday, February 07, 2001

Consensus: Key to progress
        John Williams' major lesson learned after 16 years? You can't do it all yourself.

At 30, Nasdaq a little bruised, but still standing
        NEW YORK — The Nasdaq Stock Market, the self-named “stock market for the next hundred years,” turns 30 this week, boasting of its past success and touting its plans for the future. But the market that pioneered electronic trading is also struggling with the issues of today.

Dealers warn Chrysler that cuts will hurt image
        To save more than $600 million a year as part of its turnaround plan, DaimlerChrysler AG is cutting cash payments and other subsidies to its dealers in the Tristate and nationwide.

Sunbeam files for Chapter 11
        BOCA RATON, Fla. — Struggling appliance maker Sunbeam Corp., owner of brands such as Mr. Coffee coffee makers, First Alert smoke alarms and Coleman outdoor gear, Tuesday filed for Chapter 11 bankruptcy protection to reorganize its operations.

Business Digest

Morning Memo

Tristate Business Summary

What's the buzz?

S U N D A Y   S P O T L I G H T
P&G bets on pharmaceuticals
        Only 20 miles from Procter & Gamble Co.'s world headquarters, the company's future depends on scientists in laboratories overlooking a Warren County cornfield. There, 1,100 employees of P&G Pharmaceuticals are waging a battle to compete in a $220 billion industry with a relatively tiny $850 million company.
P&G's pharmaceutical plan
It all comes back to soap